# IncobotulinumtoxinA (Xeomin) for Upper Limb Spasticity

> **NCT00465738** · PHASE3 · COMPLETED · sponsor: **Merz Pharmaceuticals GmbH** · enrollment: 216 (actual)

## Conditions studied

- Upper Limb Spasticity

## Interventions

- **DRUG:** incobotulinumtoxinA (Xeomin, also known as "NT 201" or "Botulinum toxin type A (150 kD), free from complexing proteins")

## Key facts

- **NCT ID:** NCT00465738
- **Lead sponsor:** Merz Pharmaceuticals GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2008-01
- **Final completion:** 2008-05
- **Target enrollment:** 216 (ACTUAL)
- **Last updated:** 2010-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00465738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00465738, "IncobotulinumtoxinA (Xeomin) for Upper Limb Spasticity". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00465738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*